Skip to main content

IPHA · Innate Pharma SA · Holdings

Track IPHA — free
$1.87 -0.01 (-0.53%) At close · Sep 11
Market Cap
$208.88M
Shares
111.70M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 10
Total Value: $354,043
Total Shares: 192,418

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 10 13F filers · Δ vs Mar 31, 2026
Top Holder
42.2%
Sep 2023 → Jun 2026 · range 33.6% – 65.6%
−1.9 pts
Top 5
91.5%
Sep 2023 → Jun 2026 · range 91.5% – 99.8%
−7.9 pts
Top 10
100.0%
Sep 2023 → Jun 2026 · range 100.0% – 100.0%
0.0 pts
HHI
2,582
Sep 2023 → Jun 2026 · range 2,436 – 4,953
Highly concentrated−517

Quarterly Activity

vs Mar 31, 2026
New
3
Increased
2
Decreased
3
Sold Out
2
Unchanged
2
Holder count: +1
Institutional value: +50.4%
Shares held: +4.6%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 10 of 10
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 4 filings 4 filers Visit website Investor relations